Galapagos News
Most Popular Galapagos Story
Roche boasts new data supporting Actemra, MabThera
Roche announced that a fifth Phase III rheumatoid arthritis study confirmed disease remission in patients treated with Actemra. Investigators reported that the therapy can halt structural damage to... Read more...
Latest Headlines
- October 28, 2008
- August 26, 2008
- October 24, 2007
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
